Mylan antifungals
This article was originally published in The Tan Sheet
Executive Summary
Mylan's ANDA for a generic version of Novartis' antifungal Lamisil tablets (terbinafine HCl 250 mg) gains tentative approval by FDA April 15, the firm reports. Lamisil annual sales totaled approximately $655 mil., according to Mylan...